Renuvion showed efficacy and safety when used during procedures, including lipoabdominoplasty, for the treatment of loose and lax skin, according to two new studies.
Apyx Medical’s Renuvion is a minimally invasive procedure that uses a combination of radiofrequency and helium to tighten loose skin, often in conjunction with liposuction or other surgical contouring procedures. It is U.S. Food and Drug Administration cleared for use after liposuction, improving the appearance of loose skin on the neck and chin and contracting subcutaneous soft tissue as needed, anywhere on the body.
In one study, published in Aesthetic Plastic Surgery, 76 patients were randomized to undergo lipoabdominoplasty either with or without the use of Renuvion. Patients in the Renuvion group demonstrated improvements in abdominal skin laxity and excess skin, along with higher satisfaction scores, at six months, one year, and two years post-procedure, as measured by validated BODY-Q questionnaires and independent physician-rated VAS scale scores.
The bottom line? These data demonstrated a significantly greater improvement in patients treated with Renuvion compared to those who underwent lipoabdominoplasty alone. The addition of Renuvion did not result in an increased rate of complications, the study showed.
The second publication, which appeared in Aesthetic Surgery Journal Open Forum, comprised 77 patients treated with ultrasound-assisted lipoabdominoplasty (UAL), with or without Renuvion. The study groups were similar in size and patient demographics. There were no statistically significant difference between groups in the occurrence of significant adverse events. Notably, the addition of Renuvion did not increase the incidence of significant complications, despite the Renuvion group undergoing more concurrent procedures and longer surgical times.
